Menu

Tenax Therapeutics, Inc. TENX

Full chart Compare
Set alert

Price alert · TENX

All alert types
1.69 USD +0.06 (+3.68%)

At closeNov 6, 2026, 6:05 PM EST

1.71 +0.02 +1.15%

After hours · Nov 6, 6:05 PM ET

1.62 Day range 1.72
1.36 52-week range 18.32
YTD
-86.14%
1 year
-75.58%

Revenue & Expenses

Other Income → Expenses: $784.01KExpenses → Selling, General & Admin: $7.17MExpenses → Research & Development: $6.66MExpenses → Other Operating Expenses: $1.03MExpenses → Interest Expense: $49.08KGross Profit → Expenses: $49.29KRevenue → Gross Profit: $49.29KNet Loss → Expenses: $14.08MOther Income$784.01KGross Profit$49.29KNet Loss$14.08MExpenses$14.92MSelling, General & Admin$7.17MResearch & Development$6.66MOther Operating Expenses$1.03MInterest Expense$49.08KRevenue$49.29K

Latest period ending Dec 31, 2025 · select a line to chart its full history

TENX annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-56.38M-19.49M-8.23M-11.05M-32.73M
-52.60M-17.60M-7.71M-11.05M-32.47M
-1.34-1.15-31.04-600.71-2,525.00
TENX annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
97.56M94.85M9.79M2.12M5.58M
104.23M96.69M11.69M3.40M5.99M
7.16M4.69M3.59M1.91M1.75M
97.07M91.99M8.10M1.49M4.24M
TENX annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-35.80M-14.81M-5.90M-11.39M-10.86M
38.51M99.87M13.57M7.93M9.74M
2.71M85.06M7.67M-3.46M-666.32K